UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 179 filers reported holding UNIQURE NV in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,143,356 | +181.5% | 766,521 | +380.8% | 0.00% | +300.0% |
| Q2 2023 | $1,827,010 | -78.4% | 159,425 | -62.0% | 0.00% | -83.3% |
| Q1 2023 | $8,455,981 | -9.0% | 419,860 | +2.4% | 0.01% | -25.0% |
| Q4 2022 | $9,294,722 | +10.4% | 410,001 | -8.6% | 0.01% | +33.3% |
| Q3 2022 | $8,417,000 | +51.9% | 448,694 | +50.9% | 0.01% | +20.0% |
| Q2 2022 | $5,541,000 | +98.0% | 297,339 | +92.1% | 0.01% | +150.0% |
| Q1 2022 | $2,798,000 | -26.7% | 154,812 | -15.9% | 0.00% | 0.0% |
| Q4 2021 | $3,815,000 | -33.9% | 183,977 | +2.1% | 0.00% | -33.3% |
| Q3 2021 | $5,769,000 | +22.2% | 180,250 | +17.6% | 0.00% | 0.0% |
| Q2 2021 | $4,721,000 | +3.1% | 153,241 | +12.7% | 0.00% | 0.0% |
| Q1 2021 | $4,581,000 | +642.5% | 135,969 | +695.5% | 0.00% | – |
| Q4 2020 | $617,000 | +36.5% | 17,093 | +39.5% | 0.00% | – |
| Q3 2020 | $452,000 | -61.5% | 12,256 | -53.0% | 0.00% | -100.0% |
| Q2 2020 | $1,174,000 | +28.6% | 26,082 | +35.7% | 0.00% | 0.0% |
| Q1 2020 | $913,000 | -36.3% | 19,220 | -4.0% | 0.00% | 0.0% |
| Q4 2019 | $1,434,000 | +59.3% | 20,015 | -12.5% | 0.00% | – |
| Q3 2019 | $900,000 | -12.0% | 22,874 | +75.0% | 0.00% | – |
| Q2 2019 | $1,023,000 | -8.1% | 13,073 | -29.9% | 0.00% | -100.0% |
| Q1 2019 | $1,113,000 | +554.7% | 18,649 | +216.1% | 0.00% | – |
| Q4 2018 | $170,000 | +844.4% | 5,900 | +1080.0% | 0.00% | – |
| Q3 2018 | $18,000 | +500.0% | 500 | +273.1% | 0.00% | – |
| Q1 2018 | $3,000 | -84.2% | 134 | -86.2% | 0.00% | – |
| Q4 2017 | $19,000 | -38.7% | 973 | -75.7% | 0.00% | – |
| Q3 2016 | $31,000 | -73.0% | 4,003 | -74.3% | 0.00% | – |
| Q2 2016 | $115,000 | -45.5% | 15,560 | -12.5% | 0.00% | – |
| Q1 2016 | $211,000 | -28.7% | 17,777 | -0.7% | 0.00% | – |
| Q4 2015 | $296,000 | -2.3% | 17,911 | +21.0% | 0.00% | – |
| Q3 2015 | $303,000 | -24.8% | 14,805 | -0.7% | 0.00% | – |
| Q2 2015 | $403,000 | – | 14,916 | +298220.0% | 0.00% | – |
| Q1 2015 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 5 | -98.6% | 0.00% | – |
| Q3 2014 | $3,000 | – | 364 | +1356.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 25 | -73.1% | 0.00% | – |
| Q1 2014 | $1,000 | – | 93 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |